Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qushi Hexin Fang is a Traditional Chinese Medicine (TCM) granule formulation developed by the Guangdong Provincial Hospital of Chinese Medicine. It is specifically designed to address "Dampness Syndrome" (Shi Zheng), a diagnostic category in TCM that is frequently associated with metabolic dysfunction, obesity, and chronic inflammatory states. The formula is currently being evaluated in clinical trials for its efficacy in managing metabolic syndrome and dyslipidemia. As a TCM core formula, it is composed of multiple herbal extracts intended to regulate lipid metabolism and improve systemic metabolic health by addressing the underlying TCM pathology of dampness accumulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qushi Hexin Fang.